Management Change12 Oct 2026, 08:00 pm
Cohance Lifesciences: MCA Approves Umang Vohra as Chairman & Group CEO
AI Summary
Cohance Lifesciences Ltd has received approval from the Ministry of Corporate Affairs (Central Government) for the appointment of Mr. Umang Vohra (DIN: 02296740) as Chairman and Group CEO. This approval, communicated via a letter dated 8 October 2026 and received by the company on 12 October 2026, formalizes the appointment previously indicated in letters dated 27 April 2026 and 26 June 2026. This development signifies a key leadership confirmation for the company.
Key Highlights
- Ministry of Corporate Affairs approves Mr. Umang Vohra's appointment.
- Mr. Vohra will serve as Chairman and Group CEO.
- Appointment is a formalization of previous communications.
- Key leadership change for Cohance Lifesciences Ltd.
Price Impact
More from COHANCE
More in Management Change